Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Gains from Equity Investments (2021 - 2023)

INVO Fertility (IVF) has disclosed Gains from Equity Investments for 3 consecutive years, with $8163.0 as the latest value for Q3 2023.

  • On a quarterly basis, Gains from Equity Investments fell 61.98% to $8163.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $22103.0, a 94.79% decrease, with the full-year FY2022 number at $200558.0, down 38.77% from a year prior.
  • Gains from Equity Investments was $8163.0 for Q3 2023 at INVO Fertility, up from -$3788.0 in the prior quarter.
  • In the past five years, Gains from Equity Investments ranged from a high of $214050.0 in Q4 2021 to a low of -$10007.0 in Q4 2022.
  • A 3-year average of $62245.6 and a median of $27735.0 in 2023 define the central range for Gains from Equity Investments.
  • Peak YoY movement for Gains from Equity Investments: plummeted 104.68% in 2022, then tumbled 61.0% in 2023.
  • INVO Fertility's Gains from Equity Investments stood at $214050.0 in 2021, then tumbled by 104.68% to -$10007.0 in 2022, then skyrocketed by 181.57% to $8163.0 in 2023.
  • Per Business Quant, the three most recent readings for IVF's Gains from Equity Investments are $8163.0 (Q3 2023), -$3788.0 (Q2 2023), and $27735.0 (Q1 2023).